Limb G A, Hickman-Casey J, Hollifield R D, Chignell A H
Department of Pathology, Institute of Ophthalmology and Moorfields Eye Hospital, London, United Kingdom.
Invest Ophthalmol Vis Sci. 1999 Sep;40(10):2453-7.
To investigate whether proliferative vitreoretinopathy (PDR) is associated with a selective increase in vitreous levels of soluble vascular cell adhesion molecules that mediate leukocyte extravasation and interaction with endothelium during processes of inflammation and neovascularization.
Vitreous from 55 patients undergoing vitrectomy for treatment of PDR complicated by vitreous hemorrhage and/or traction retinal detachment was assayed for the presence of the soluble vascular cell adhesion molecules sICAM-1, sVCAM-1, and sE-selectin using a standard enzyme-linked immunosorbent assays (ELISA). Vitreous from 12 cadaveric eyes matching age and sex of the patients were used as control samples.
Vitreous levels of sICAM-1, sVCAM-1, and sE-selectin were significantly higher in eyes with PDR than in control cadaveric vitreous, and levels of all three molecules did not relate to the type or duration of diabetes mellitus. However, eyes with either traction retinal detachment alone or both traction retinal detachment and vitreous hemorrhage exhibited significantly higher levels of sICAM-1 and sE-selectin than eyes with vitreous hemorrhage alone. Vitreous levels of sVCAM-1 were similar in eyes with either vitreous hemorrhage or traction retinal detachment alone.
The present observations suggest that molecular inflammatory mechanisms may contribute to processes of neovascularization and fibrosis observed in PDR, possibly not as the causative event, but as a result of endothelial, Müller, and retinal pigment epithelial cell activation. The results also indicate that retinal detachment amplifies the existing inflammation within the diabetic retina. Identification of any abnormalities in the production and control of specific adhesion molecules could have important implications in the design of new therapeutic regimens to treat and prevent this sight-threatening complication of diabetes mellitus.
研究增殖性玻璃体视网膜病变(PDR)是否与玻璃体中可溶性血管细胞黏附分子水平的选择性升高有关,这些分子在炎症和新生血管形成过程中介导白细胞外渗以及与内皮细胞的相互作用。
采用标准酶联免疫吸附测定(ELISA)法,检测55例因PDR合并玻璃体出血和/或牵引性视网膜脱离而接受玻璃体切除术患者的玻璃体中可溶性血管细胞黏附分子sICAM-1、sVCAM-1和sE-选择素的存在情况。选取12只年龄和性别与患者匹配的尸体眼的玻璃体作为对照样本。
PDR患者眼中sICAM-1、sVCAM-1和sE-选择素的玻璃体水平显著高于对照尸体眼玻璃体,且这三种分子的水平与糖尿病的类型或病程无关。然而,仅患有牵引性视网膜脱离或同时患有牵引性视网膜脱离和玻璃体出血的眼,其sICAM-1和sE-选择素水平显著高于仅患有玻璃体出血的眼。仅患有玻璃体出血或牵引性视网膜脱离的眼中sVCAM-1的玻璃体水平相似。
目前的观察结果表明,分子炎症机制可能参与了PDR中观察到的新生血管形成和纤维化过程,可能并非作为致病事件,而是内皮细胞、米勒细胞和视网膜色素上皮细胞活化的结果。结果还表明,视网膜脱离会加剧糖尿病视网膜内现有的炎症。识别特定黏附分子产生和调控中的任何异常,可能对设计治疗和预防这种糖尿病致盲性并发症的新治疗方案具有重要意义。